Association of sodium-glucose co-transporter-2 inhibitors with cardiac outcomes and mortality in cancer patients: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ...

Type 2 diabetes patients starting on SGLT2 inhibitors had a sightly lower risk of autoimmune rheumatic diseases compared with ...

"Dapagliflozin reduced UACR compared with placebo, although considerable variability was observed among individuals. These variations, which were consistent after re-exposure, underscore the need for ...

The DapaTAVI trial previously showed reduced rates of death or worsening heart failure with dapagliflozin in older adults with aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) ...